期刊文献+

3T3-L1脂肪细胞膜FGF-21结合蛋白的初步鉴定 被引量:3

Identification of Binding Partners of Fibroblast Growth Factor-21 in Cell Membrane of 3T3-L1 Cells
原文传递
导出
摘要 成纤维细胞生长因子(fibroblast growth factor,FGF)-21是最近发现的1个可以独立调节血糖的细胞因子,有望成为治疗2型糖尿病的备选药物.但是,FGF-21调解血糖的机理尚不十分清楚.为探讨该因子功能受体,应用偶联方法,以3T3-L1脂肪细胞为靶标,以FGF-21为诱饵,在3T3-L1脂肪细胞膜上寻找结合蛋白.结果表明,生物素标记的FGF-21可与脂肪细胞膜蛋白形成分子质量大小约300kD以上两组复合物.竞争试验显示,非标记的FGF-21可与生物素标记的FGF-21竞争、抑制标记的FGF-21参入复合物;应用非标记FGF-21剂量越大,抑制后者参入复合物的程度越强.结果提示,该复合物是FGF-21特异性的.此外,随着生物素标记的FGF-21剂量增加,观察到的标记复合物越多;但是,当FGF-21剂量达12.5mg/L以上时,观察到的复合物数量不再增加.实验结果提示,复合物形成与FGF-21剂量相关;FGF-21特异结合的蛋白质结合位点饱和后,复合物形成量最大.同时,采用FGF受体特异性抑制剂SU5402可特异性抑制FGF-21在3T3-L1脂肪细胞中的促进葡萄糖吸收作用,提示本实验所观察到的FGF-21-膜蛋白复合物可能就是FGF-21-FGF受体. Fibroblast growth factor (FGF)-21 is a novel regulator of insulin-independent glucose transport, and could be a potential therapeutic agent for treatment of type Ⅱ diabetes. However, the precise mechanisms whereby FGF-21 regulates blood glucose metabolism remain unknown. In order to study the function of FGF-21 receptor, cross-link method was utilized; 3T3-L1 adipocytes were used as target cells and FGF-21 was used as a bait to search for binding partners from 3T3-L1 cell membrane. Biotinylated FGF-21 could form two complexes with cell membrane proteins of 3T3-L1 adipocytes. The size of the complexes was more than 300 kD. Competition experiment showed that the cold FGF-21 could compete with labeled FGF-21 in forming the complexes, the higher dose of the cold FGF-21 was used, the stronger inhibition of the complex formation was observed. These results suggest that the complexes are FGF-21-specific. In addition, the yield of the complexes increased with increment of the biotinylated FGF-21 added to the reaction. However, the complexes became saturated when FGF-21 concentration reached to 12.5 mg/L or more. The result suggests that the formation of the complexes is FGF-21-dependent. After the binding sites of the FGF-21-associated proteins were saturated, the quantity of complexes reached a maximum. Furthermore, FGF receptor inhibitor SU5402 could restrain FGF-21-induced glucose up-take in 3T3-L1 adipocytes, suggesting that the complexes might be the FGF-21-FGF receptor.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2008年第7期667-673,共7页 Chinese Journal of Biochemistry and Molecular Biology
基金 黑龙江省科技厅重点攻关项目(No2006G0461-00)~~
关键词 成纤维细胞生长因子-21(FGF-21) 脂肪细胞 复合物鉴定 fibroblast growth factor-21 (FGF-21) adipocytes complex identification
  • 相关文献

参考文献15

  • 1Mohammadi M, Olsen S K, Ibrahimi O A. Structural basis for fibroblast growth factor receptor activation[J]. Cytokine Growth Factor Rev, 2005,16 (2): 107-137
  • 2李江红,张宗玉,童坦君.肽类生长因子对抗癌基因的诱导作用[J].生物化学杂志,1994,10(5):626-629. 被引量:2
  • 3Nishimura T, Nakatake Y, Konishi M, et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver [J]. Biochim Biophys Acta, 2000, 1492( 1 ) : 203-206
  • 4Kharitonenkov A, Shiyanova T L, Koester A, et al. FGF-21 as a novel metabolic regulator[J]. J Clin Invest, 2005, 115(6) : 1627- 1635
  • 5Wente W, Efanov A M, Brenner M, et al. Fibroblast growth factor- 21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways [J]. Diabetes, 2006, 55(9): 2470-2478
  • 6Kharitonenkov A, Wroblewski V J, Koester A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21 [J]. Endocrinology, 2007, 148(2): 774-781
  • 7张崇本,张晓兰,李成健,成俊英,吴显荣.小鼠3T3-L1前脂肪细胞系的特异性标记(英文)[J].中国生物化学与分子生物学报,2004,20(5):583-586. 被引量:2
  • 8Mohammadi M, McMahon G, Sun L, et al. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors[ J]. Science, 276(5314) : 955-960
  • 9Huang X, Yu C, Jin C, et al. Forced expression of hepatocytespecific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis [ J ]. Mol Carcinog, 2006, 45 ( 12 ) : 934-942
  • 10Powers C J, McLeskey S W, Wellstein A. Fibroblast growth factors, their receptors and signaling[J]. Endocr Relat Cancer, 2000, 7(3) : 165-197

二级参考文献11

  • 1[1]Hoist D, Grimaldi P A. New factors in the regulation of adipose differentiation and metabolism. Curr Opin Lipidol, 2002, 13 (3): 241~ 245
  • 2[2]Guerre-Millo M. Adipose tissue hormones. J Endocrinol Invest, 2002,25(10) :855 ~ 861
  • 3[4]Coe N R, Bernlonr D A, Flier J S, Physiological properties of and functions of intracellular fatty acid-binding protein. Biochim Biophys Acta, 2000, 1391(3) :287 ~ 306
  • 4[5]Uysal K T, Scheja L, Hotamisligil G S. Improved Glucose and lipid metabolism in Genetically obese mice lacking aP2. Endocrinology,2000, 141:3388 ~ 3396
  • 5[6]Hotamisligil G S, Johnson R S, Distel R J, Ellis R, Papaioannou V E,Spiegelman B M. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein.Science, 1996, 274:1377 ~ 1379
  • 6[7]Hunt C R, Ro J H, Dobson D E, Min H Y, Spiegelman B M.Adipocyte P2 gene: developmental expression and homology of 5'flanking sequences among fat cell-specific genes. Proc Natl Acad Sci USA, 1986, 83:3786 ~ 3790
  • 7[8]Ross S R, Graves R A, Greenstein A, Platt K A, Shyu H L, Mellovitz B, Spiegelman B M. A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo . Proc Natl Acad Sci USA,1990, 87(24) :9590 ~ 9594
  • 8[9]Green H. An established cell line and its differentiation in culture Ⅱ:Factors affecting adipose conversion. Cell, 1975, 5:19 ~ 27
  • 9[10]Chalfie M. Green fluorescent protein. Photochem Photobiol, 1995, 62:651 ~ 656
  • 10[11]Zhang C B, Teng L, Shang K G, Xue Y F, Gu J. Effects ofemodin on proliferation and differentiation of 3T3-L1 preadipocytes and activities of FAS in vitro. Chin Med J, 2002, 115(7): 1035 ~ 1038

共引文献2

同被引文献57

  • 1郑青,彭菲,苏志坚,吴晓萍,许华,李校堃.haFGF和nm-haFGF过表达对乳腺肿瘤细胞增殖及c-fos、c-jun mRNA表达的影响[J].中国药理学通报,2006,22(4):402-407. 被引量:5
  • 2胡文娟,黄巨恩,李校堃,肖健.改构型酸性成纤维细胞生长因子对大鼠肾缺血/再灌注损伤的保护作用[J].中国药理学通报,2007,23(2):166-169. 被引量:15
  • 3Omitz D M, hob N. Fibroblast growth factors[J]. Genome Biol, 2001,2 ( 3 ) : Review 3005.
  • 4Nishimura T, Nakatake Y, Konishi M, et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver[ J ]. Biochim Biophys Acta, 2000,1492( 1 ) : 203 - 6.
  • 5Kharitonenkov A, Shiyanova T L, Li D S, et al. FGF-21 as a novel metabolic regulator[ J]. J Clin Invest, 2005,115 ( 6 ) : 1627 - 35.
  • 6Wente W, Efanov A M, Brenner M, et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways [ J 1. Diabetes, 2006,55 (9) : 2470 - 8.
  • 7Arner P, Pettersson A, Mitchell P J, et al. FGF21 attenuates lipolysis in human adipocytes-a possible link to improved insulin sensitivity[ J ]. FEBS Lett ,2008,552 ( 12 ) : 1725 - 30.
  • 8Kharitonenkov A, Wroblewski V J, Koester A, et al. The meta- bolic state of diabetic monkeys is regulated by fibroblast growth factor-21 [ J]. Endocrinology, 2007,148(2) : 774 - 81.
  • 9Badman M K, Pissios P, Kennedy A R, et al. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states[ J]. Cell Metab, 2007, 5(6) :426 -37.
  • 10Yamauchi H, Hotta Y, Konishi M, et al. Fgf21 is essential for haematopoiesis in zebrafish [ J ]. EMBO Rep, 2006,7 ( 6 ) : 649 - 54.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部